BLDR three-lens brief
Evidence-based stock research on BLDR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.51% yesterday. · Trading at 13% of its 52-week range — deep in the lower band.
- Moved +2.51% yesterday.
- Trading at 13% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $99.05 — 30% above current (21 analysts).
- Earnings scheduled 2026-07-30.
BLDR closed at $76.41 (+2.51%) as of 2026-07-10. Market cap: $8.22B. P/E (trailing) 29.2. Price is below the 50-day MA and below the 200-day MA. Positives: moved +2.51% yesterday.; analyst mean target $99.05 — 30% above current (21 analysts).. Concerns: trading at 13% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $3.29B, net income -$47.41M, free cash flow $640.90M. Watching for: 2026-07-30 earnings release (19 days out).
Why three lenses on BLDR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BLDRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BLDR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BLDR brief"></iframe>